PFM
Privium Fund Management Portfolio holdings
AUM
$464M
This Quarter Return
+31.78%
1 Year Return
+124.83%
3 Year Return
+508.69%
5 Year Return
–
10 Year Return
–
AUM
$464M
AUM Growth
+$464M
(+21%)
Cap. Flow
-$4.03M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
81.5%
Holding
63
New
7
Increased
24
Reduced
7
Closed
8
Top Buys
| 1 |
Coinbase
COIN
|
$24.2M |
| 2 |
Tesla
TSLA
|
$6.79M |
| 3 |
Biogen
BIIB
|
$2.67M |
| 4 |
Amazon
AMZN
|
$1.76M |
| 5 |
Shopify
SHOP
|
$1.71M |
Top Sells
| 1 |
Spotify
SPOT
|
$23.1M |
| 2 |
Snowflake
SNOW
|
$7.13M |
| 3 |
Cloudflare
NET
|
$6.76M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$5.47M |
| 5 |
uniQure
QURE
|
$1.84M |
Sector Composition
| 1 | Consumer Discretionary | 30.56% |
| 2 | Technology | 23.32% |
| 3 | Healthcare | 20.6% |
| 4 | Communication Services | 18.3% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roivant Sciences
ROIV
$8.15B
| $1.39M | 0.3% | 126,923 | – | – |
|
27
Avidity Biosciences
RNA
$5.99B
| $1.31M | 0.28% | 46,000 +11,500 | +33% | +$327K |
|
28
Krystal Biotech
KRYS
$4.27B
| $1.3M | 0.28% | 9,320 +1,810 | +24% | +$252K |
|
29
BioNTech
BNTX
$24B
| $1.18M | 0.25% | +10,987 | New | +$1.18M |
|
30
Rocket Pharmaceuticals
RCKT
$354M
| $1.12M | 0.24% | 432,760 | – | – |
|
31
Hims & Hers Health
HIMS
$9.57B
| $1.1M | 0.24% | +22,000 | New | +$1.1M |
|
32
MeiraGTx Holdings
MGTX
$587M
| $1.06M | 0.23% | 163,000 +46,000 | +39% | +$298K |
|
33
Pfizer
PFE
$141B
| $927K | 0.2% | 37,029 +4,702 | +15% | +$118K |
|
34
Wave Life Sciences
WVE
$1.53B
| $884K | 0.19% | 135,550 +22,000 | +19% | +$143K |
|
35
Pan American Silver
PAAS
$12.3B
| $845K | 0.18% | 29,747 +8,463 | +40% | +$240K |
|
36
NOV
NOV
$4.94B
| $825K | 0.18% | 63,876 +14,131 | +28% | +$183K |
|
37
4D Molecular Therapeutics
FDMT
$288M
| $819K | 0.18% | 197,458 +66,458 | +51% | +$276K |
|
38
Sprott Uranium Miners ETF
URNM
$1.67B
| $761K | 0.16% | 16,278 +4,164 | +34% | +$195K |
|
39
Lexeo Therapeutics
LXEO
$259M
| $753K | 0.16% | 178,356 +18,158 | +11% | +$76.6K |
|
|
VZLA
40
Vizsla Silver
VZLA
$1.26B
| $732K | 0.16% | 250,790 +58,303 | +30% | +$170K |
|
41
Sarepta Therapeutics
SRPT
$1.78B
| $698K | 0.15% | +39,400 | New | +$698K |
|
|
AUTL
42
Autolus Therapeutics
AUTL
$399M
| $674K | 0.15% | 294,142 +42,468 | +17% | +$97.3K |
|
|
SA
43
Seabridge Gold
SA
$1.78B
| $648K | 0.14% | 44,074 | – | – |
|
44
Recursion Pharmaceuticals
RXRX
$2.04B
| $610K | 0.13% | 119,000 | – | – |
|
45
Valaris
VAL
$3.54B
| $606K | 0.13% | 13,803 -6,419 | -32% | -$282K |
|
|
EMX
46
EMX Royalty
EMX
$398M
| $545K | 0.12% | 216,968 | – | – |
|
47
SandRidge Energy
SD
$435M
| $401K | 0.09% | 37,022 +13,722 | +59% | +$149K |
|
48
Noble Corp
NE
$4.58B
| $392K | 0.08% | 14,287 | – | – |
|
49
Taysha Gene Therapies
TSHA
$797M
| $316K | 0.07% | 134,900 | – | – |
|
50
Tidewater
TDW
$2.98B
| $255K | 0.06% | +5,350 | New | +$255K |
|